The veterinary tranquilizer xylazine is being associated with a rising count of overdose fatalities across the country amidst the ongoing crisis of drug addiction and overdose. Persons are often exposed to xylazine unintentionally through adulterated heroin/fentanyl products. Data on this critical public health threat are just emerging and suggest that xylazine exposure changes the experience of fentanyl and may lead to medical consequences such as skin ulcers. There exist pressing gaps in the surveillance and medical treatment of xylazine, whichKelly E. Dunn, Ph.D., M.B.A. (at DrKellyDunn) will explore in this webinar, focusing on areas where inventive solutions are urgently required.

After Dr. Dunn’s talk, Dr. Supriya Munshaw will discuss the I4SUD program and how it can help researchers bring their inventive solutions to market.

For registration, click here!